N-acetyl-L-cysteine	O
inhibits	O
primary	O
human	O
T	O
cell	O
responses	O
at	O
the	O
dendritic	O
cell	O
level	O
:	O
association	O
with	O
NF-kappaB	B-protein
inhibition	O
.	O

N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
is	O
an	O
antioxidant	O
molecule	O
endowed	O
with	O
immunomodulatory	O
properties	O
.	O

To	O
investigate	O
the	O
effect	O
of	O
NAC	O
on	O
the	O
induction	O
phase	O
of	O
T	O
cell	O
responses	O
,	O
we	O
analyzed	O
its	O
action	O
on	O
human	O
dendritic	O
cells	O
(	O
DC	O
)	O
derived	O
from	O
adherent	O
PBMC	O
cultured	O
with	O
IL-4	B-protein
and	O
granulocyte-macrophage	B-protein
CSF	I-protein
.	O

We	O
first	O
found	O
that	O
NAC	O
inhibited	O
the	O
constitutive	O
as	O
well	O
as	O
the	O
LPS-induced	O
activity	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kappaB	B-protein
.	O

In	O
parallel	O
,	O
NAC	O
was	O
shown	O
to	O
down-regulate	O
the	O
production	O
of	O
cytokines	B-protein
by	O
DC	B-cell_type
as	O
well	O
as	O
their	O
surface	O
expression	O
of	O
HLA-DR	B-protein
,	O
CD86	B-protein
(	O
B7-2	B-protein
)	O
,	O
and	O
CD40	B-protein
molecules	I-protein
both	O
at	O
the	O
basal	O
state	O
and	O
upon	O
LPS	O
activation	O
.	O

NAC	O
also	O
inhibited	O
DC	O
responses	O
induced	O
by	O
CD40	B-protein
engagement	O
.	O

The	O
inhibitory	O
effects	O
of	O
NAC	O
were	O
not	O
due	O
to	O
nonspecific	O
toxicity	O
as	O
neither	O
the	O
viability	O
of	O
DC	B-cell_type
nor	O
their	O
mannose	O
receptor-mediated	O
endocytosis	O
were	O
modified	O
by	O
NAC	O
.	O

Finally	O
,	O
we	O
found	O
that	O
the	O
addition	O
of	O
NAC	O
to	O
MLR	O
between	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
allogeneic	O
DC	B-cell_type
resulted	O
in	O
a	O
profound	O
inhibition	O
of	O
alloreactive	O
responses	O
,	O
which	O
could	O
be	O
attributed	O
to	O
a	O
defect	O
of	O
DC	B-cell_type
as	O
APC-independent	O
T	O
cell	O
responses	O
were	O
not	O
inhibited	O
by	O
NAC	O
.	O

Altogether	O
,	O
our	O
results	O
suggest	O
that	O
NAC	O
might	O
impair	O
the	O
generation	O
of	O
primary	O
immune	O
responses	O
in	O
humans	O
through	O
its	O
inhibitory	O
action	O
on	O
DC	B-cell_type
.	O

K	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
Le	NULL
meJournal	NULL
o	NULL
N-Acetyl-l-Cysteine	NULL
Inhibits	NULL
Primary	NULL
Human	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
T	NULL
Cell	NULL
Responses	NULL
at	NULL
the	NULL
Dendritic	NULL
Cell	NULL
Level	NULL
:	NULL
Association	NULL
with	NULL
NF-xB	NULL
Inhibition	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Valérie	NULL
Verhasselt	NULL
,	NULL
Wim	NULL
Vanden	NULL
Berghe	NULL
,	NULL
Nathalie	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
(	NULL
Elana	NULL
;	NULL
i	NULL
)	NULL
;	NULL
is	NULL
current	NULL
as	NULL
Vanderheyde	NULL
,	NULL
Fabienne	NULL
Willems	NULL
,	NULL
Guy	NULL
Haegeman	NULL
and	NULL
Michel	NULL
'	NULL
|	NULL
Goldman	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162	NULL
;	NULL
:2569-2574	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/5/2569	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
40	NULL
articles	NULL
,	NULL
24	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/5/2569.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
N-Acetyl-L-Cysteine	NULL
Inhibits	NULL
Primary	NULL
Human	NULL
T	NULL
Cell	NULL
Responses	NULL
at	NULL
the	NULL
Dendritic	NULL
Cell	NULL
Level	NULL
:	NULL
Association	NULL
with	NULL
NF-B	NULL
Inhibition	NULL
Valérie	NULL
Verhasselt	NULL
,	NULL
*	NULL
Wim	NULL
Vanden	NULL
Berghe	NULL
,	NULL
``	NULL
Nathalie	NULL
Vanderheyde	NULL
,	NULL
*	NULL
Fabienne	NULL
Willems	NULL
,	NULL
*	NULL
Guy	NULL
Haegeman	NULL
,	NULL
'	NULL
and	NULL
Michel	NULL
Goldman	NULL
``	NULL
*	NULL
N-acetyl-L-cysteine	NULL
(	NULL
NAC	NULL
)	NULL
is	NULL
an	NULL
antioxidant	NULL
molecule	NULL
endowed	NULL
with	NULL
immunomodulatory	NULL
properties	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
induction	NULL
phase	NULL
of	NULL
T	NULL
cell	NULL
responses	NULL
,	NULL
we	NULL
analyzed	NULL
its	NULL
action	NULL
on	NULL
human	NULL
dendritic	NULL
cells	NULL
(	NULL
DC	NULL
)	NULL
derived	NULL
from	NULL
adherent	NULL
PBMC	NULL
cultured	NULL
with	NULL
IL-4	NULL
and	NULL
granulocyte-macrophage	NULL
CSF	NULL
.	NULL

We	NULL
first	NULL
found	NULL
that	NULL
NAC	NULL
inhibited	NULL
the	NULL
constitutive	NULL
as	NULL
well	NULL
as	NULL
the	NULL
LPS-induced	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
NAC	NULL
was	NULL
shown	NULL
to	NULL
down-regulate	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
by	NULL
DC	NULL
as	NULL
well	NULL
as	NULL
their	NULL
surface	NULL
expression	NULL
of	NULL
HLA-DR	NULL
,	NULL
CD86	NULL
(	NULL
B7-2	NULL
)	NULL
,	NULL
and	NULL
CD40	NULL
molecules	NULL
both	NULL
at	NULL
the	NULL
basal	NULL
state	NULL
and	NULL
upon	NULL
LPS	NULL
activation	NULL
.	NULL

NAC	NULL
also	NULL
inhibited	NULL
DC	NULL
responses	NULL
induced	NULL
by	NULL
CD40	NULL
engagement	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
NAC	NULL
were	NULL
not	NULL
due	NULL
to	NULL
nonspecific	NULL
toxicity	NULL
as	NULL
neither	NULL
the	NULL
viability	NULL
of	NULL
DC	NULL
nor	NULL
their	NULL
mannose	NULL
receptor-mediated	NULL
endocytosis	NULL
were	NULL
modified	NULL
by	NULL
NAC	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
NAC	NULL
to	NULL
MLR	NULL
between	NULL
naive	NULL
T	NULL
cells	NULL
and	NULL
allogeneic	NULL
DC	NULL
resulted	NULL
in	NULL
a	NULL
profound	NULL
inhibition	NULL
of	NULL
alloreactive	NULL
responses	NULL
,	NULL
which	NULL
could	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
defect	NULL
of	NULL
DC	NULL
as	NULL
APC-independent	NULL
T	NULL
cell	NULL
responses	NULL
were	NULL
not	NULL
inhibited	NULL
by	NULL
NAC	NULL
.	NULL

Altogether	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
NAC	NULL
might	NULL
impair	NULL
the	NULL
generation	NULL
of	NULL
primary	NULL
immune	NULL
responses	NULL
in	NULL
humans	NULL
through	NULL
its	NULL
inhibitory	NULL
action	NULL
on	NULL
DC	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
2569-2574	NULL
.	NULL

-acetyl-L-cysteine	NULL
(	NULL
NAC	NULL
)	NULL
,	NULL
``	NULL
an	NULL
old	NULL
medicine	NULL
classically	NULL
leed	NULL
as	NULL
a	NULL
mucolytic	NULL
agent	NULL
,	NULL
has	NULL
recently	NULL
gained	NULL
new	NULL
interest	NULL
in	NULL
view	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
inhibit	NULL
HIV	NULL
replication	NULL
(	NULL
1-6	NULL
)	NULL
and	NULL
the	NULL
synthesis	NULL
of	NULL
proinflammatory	NULL
molecules	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
of	NULL
NAC	NULL
depend	NULL
on	NULL
its	NULL
antioxidant	NULL
properties	NULL
related	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
thiol	NULL
group	NULL
and	NULL
resulting	NULL
in	NULL
inhibition	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
redox	NULL
potential	NULL
of	NULL
the	NULL
cell	NULL
and/or	NULL
by	NULL
the	NULL
production	NULL
of	NULL
radical	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

9-11	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
direct	NULL
antioxidant	NULL
properties	NULL
,	NULL
NAC	NULL
also	NULL
acts	NULL
by	NULL
increasing	NULL
the	NULL
cellular	NULL
content	NULL
in	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
,	NULL
the	NULL
major	NULL
intracellular	NULL
redox	NULL
buffer	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
GSH	NULL
content	NULL
of	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
their	NULL
responses	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
(	NULL
12-16	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
GSH	NULL
deficiency	NULL
in	NULL
T	NULL
cells	NULL
would	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
patho-genesis	NULL
of	NULL
AIDS	NULL
(	NULL
4	NULL
,	NULL
6	NULL
)	NULL
and	NULL
common	NULL
variable	NULL
immunodeficiency	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
NAC	NULL
may	NULL
improve	NULL
T	NULL
cell	NULL
functions	NULL
in	NULL
these	NULL
conditions	NULL
.	NULL

However	NULL
,	NULL
the	NULL
stimulatory	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
hu-	NULL
*Laboratory	NULL
of	NULL
Experimental	NULL
Immunology	NULL
and	NULL
Centre	NULL
de	NULL
Recherche	NULL
Interuniversitaire	NULL
en	NULL
Vaccinologic	NULL
,	NULL
Université	NULL
Libre	NULL
de	NULL
Bruxelles	NULL
,	NULL
Brussels	NULL
,	NULL
Belgium	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Flanders	NULL
Interuniversity	NULL
Institute	NULL
for	NULL
Biotechnology	NULL
,	NULL
University	NULL
of	NULL
Gent	NULL
,	NULL
Belgium	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
19	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
November	NULL
12	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Interuniversity	NULL
Attraction	NULL
Poles	NULL
of	NULL
the	NULL
Belgian	NULL
Federal	NULL
Ministry	NULL
for	NULL
Scientific	NULL
Research	NULL
.	NULL

V.V	NULL
.	NULL

is	NULL
a	NULL
research	NULL
fellow	NULL
of	NULL
the	NULL
Fonds	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
(	NULL
Belgium	NULL
)	NULL
.	NULL

The	NULL
Centre	NULL
de	NULL
Recherche	NULL
Interuniversitaire	NULL
en	NULL
Vaccinologie	NULL
is	NULL
sponsored	NULL
by	NULL
Smith	NULL
Kline	NULL
Beecham	NULL
Biologicals	NULL
and	NULL
the	NULL
Région	NULL
Wallonne	NULL
.	NULL

G.H	NULL
.	NULL

is	NULL
a	NULL
Research	NULL
Director	NULL
of	NULL
the	NULL
Fonds	NULL
voor	NULL
Wetenschappelijk	NULL
Onderzock-Vlaanderen	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Michel	NULL
Goldman	NULL
,	NULL
Hopital	NULL
Erasme	NULL
,	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
808	NULL
route	NULL
de	NULL
Lennik	NULL
,	NULL
B-1070	NULL
Brussels	NULL
,	NULL
Bel-gium	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
mgoldman	NULL
@	NULL
resulb.ulb.ac.be	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
NAC	NULL
,	NULL
N-acetyl-L-cysteine	NULL
;	NULL
DC	NULL
,	NULL
dendritic	NULL
cell	NULL
;	NULL
ROL	NULL
,	NULL
radical	NULL
oxygen	NULL
intermediates	NULL
;	NULL
GSH	NULL
,	NULL
glutathione	NULL
;	NULL
BSO	NULL
,	NULL
L-buthionine	NULL
sulfoxi-mine	NULL
;	NULL
CD40L	NULL
,	NULL
CD40	NULL
ligand	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
;	NULL
GM	NULL
,	NULL
granulocyte-macrophage	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
man	NULL
T	NULL
cells	NULL
have	NULL
only	NULL
been	NULL
documented	NULL
in	NULL
systems	NULL
in	NULL
which	NULL
T	NULL
cell	NULL
activation	NULL
does	NULL
not	NULL
depend	NULL
on	NULL
accessory	NULL
signals	NULL
delivered	NULL
by	NULL
APC	NULL
(	NULL
12-16	NULL
)	NULL
.	NULL

During	NULL
a	NULL
primary	NULL
immune	NULL
response	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
depends	NULL
on	NULL
their	NULL
interactions	NULL
with	NULL
dendritic	NULL
cells	NULL
(	NULL
DC	NULL
)	NULL
,	NULL
a	NULL
highly	NULL
specialized	NULL
population	NULL
of	NULL
APC	NULL
that	NULL
express	NULL
constitutively	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
18-24	NULL
)	NULL
.	NULL

DC	NULL
have	NULL
the	NULL
unique	NULL
ability	NULL
to	NULL
stimulate	NULL
naive	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
expression	NULL
on	NULL
their	NULL
membrane	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
,	NULL
which	NULL
are	NULL
critical	NULL
for	NULL
Ag	NULL
presentation	NULL
to	NULL
Th	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
costimulatory	NULL
molecules	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
B7	NULL
molecules	NULL
)	NULL
that	NULL
deliver	NULL
accessory	NULL
signals	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

To	NULL
get	NULL
further	NULL
insight	NULL
into	NULL
the	NULL
immune	NULL
effects	NULL
of	NULL
NAC	NULL
,	NULL
we	NULL
determined	NULL
its	NULL
effects	NULL
on	NULL
human	NULL
DC	NULL
,	NULL
paying	NULL
particular	NULL
attention	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
,	NULL
cytokine	NULL
production	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
costimulatory	NULL
molecules	NULL
both	NULL
at	NULL
the	NULL
basal	NULL
state	NULL
and	NULL
upon	NULL
activation	NULL
induced	NULL
by	NULL
either	NULL
LPS	NULL
or	NULL
CD40	NULL
engagement	NULL
(	NULL
25-29	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
DC	NULL
to	NULL
elicit	NULL
a	NULL
primary	NULL
alloreactive	NULL
T	NULL
cell	NULL
response	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Medium	NULL
and	NULL
reagents	NULL
Culture	NULL
medium	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
DC	NULL
consisted	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Paisley	NULL
,	NULL
Scotland	NULL
)	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
20	NULL
ug/tol	NULL
gentamicin	NULL
,	NULL
50	NULL
M	NULL
2-ME	NULL
,	NULL
1	NULL
%	NULL
nonessential	NULL
amino	NULL
acids	NULL
(	NULL
Life	NULL
Tech-nologies	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
Myoclone	NULL
;	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

For	NULL
all	NULL
subsequent	NULL
experiments	NULL
,	NULL
culture	NULL
medium	NULL
was	NULL
devoid	NULL
of	NULL
2-ME	NULL
.	NULL

IL-4	NULL
was	NULL
purchased	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Recombinant	NULL
granulocyte-macrophage	NULL
(	NULL
GM	NULL
)	NULL
-CSF	NULL
was	NULL
obtained	NULL
from	NULL
Schering-Plough	NULL
(	NULL
Brussels	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

NAC	NULL
,	NULL
L-buthionine	NULL
sulfoximine	NULL
(	NULL
BSO	NULL
)	NULL
,	NULL
and	NULL
LPS	NULL
from	NULL
Escherichia	NULL
coli	NULL
(	NULL
serotype	NULL
0128	NULL
:	NULL
B12	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
Bornem	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

NAC	NULL
was	NULL
dissolved	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
pH	NULL
was	NULL
adjusted	NULL
to	NULL
7.4	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
NaOH	NULL
.	NULL

Cell	NULL
preparations	NULL
DC	NULL
were	NULL
generated	NULL
from	NULL
PBMC	NULL
as	NULL
described	NULL
by	NULL
Romani	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
PBMC	NULL
from	NULL
healthy	NULL
volunteers	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
centrif-ugation	NULL
of	NULL
heparinized	NULL
blood	NULL
on	NULL
Lymphoprep	NULL
(	NULL
Nycomed	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
culture	NULL
medium	NULL
,	NULL
and	NULL
allowed	NULL
to	NULL
adhere	NULL
to	NULL
6-well	NULL
plates	NULL
.	NULL

After	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2570	NULL
cultured	NULL
in	NULL
3	NULL
ml	NULL
of	NULL
medium	NULL
containing	NULL
GM-CSF	NULL
(	NULL
800	NULL
U/ml	NULL
)	NULL
and	NULL
IL-4	NULL
(	NULL
500	NULL
U/ml	NULL
)	NULL
.	NULL

Every	NULL
2	NULL
days	NULL
,	NULL
300	NULL
pl	NULL
of	NULL
medium	NULL
were	NULL
removed	NULL
and	NULL
replaced	NULL
by	NULL
the	NULL
same	NULL
volume	NULL
of	NULL
fresh	NULL
medium	NULL
containing	NULL
2400	NULL
U	NULL
of	NULL
GM-CSF	NULL
and	NULL
1500	NULL
U	NULL
of	NULL
IL-4	NULL
.	NULL

After	NULL
7	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
DC	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
used	NULL
for	NULL
subsequent	NULL
experiments	NULL
.	NULL

The	NULL
resulting	NULL
cell	NULL
preparation	NULL
contained	NULL
>	NULL
90	NULL
%	NULL
DC	NULL
as	NULL
assessed	NULL
by	NULL
morphology	NULL
and	NULL
FACS	NULL
analysis	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
purified	NULL
from	NULL
PBMC	NULL
using	NULL
Lympho-Kwik	NULL
(	NULL
One	NULL
Lambda	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
they	NULL
were	NULL
>	NULL
90	NULL
%	NULL
pure	NULL
as	NULL
assessed	NULL
by	NULL
FACS	NULL
.	NULL

Naive	NULL
CD45	NULL
*	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
in	NULL
two	NULL
steps	NULL
using	NULL
magnetic	NULL
cell	NULL
separation	NULL
columns	NULL
and	NULL
Ab	NULL
mixture	NULL
(	NULL
Miltenyi	NULL
Biotech	NULL
,	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
:	NULL
an	NULL
initial	NULL
step	NULL
of	NULL
negative	NULL
selection	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
was	NULL
followed	NULL
by	NULL
a	NULL
second	NULL
step	NULL
of	NULL
negative	NULL
selection	NULL
of	NULL
CDASRA	NULL
*	NULL
cells	NULL
.	NULL

CDASRA	NULL
*	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
>	NULL
95	NULL
%	NULL
pure	NULL
as	NULL
assessed	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

DC	NULL
cultures	NULL
A	NULL
total	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
DC	NULL
were	NULL
cultured	NULL
during	NULL
24	NULL
h	NULL
in	NULL
a	NULL
24-well	NULL
plate	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
NAC	NULL
.	NULL

To	NULL
test	NULL
the	NULL
role	NULL
of	NULL
GSH	NULL
in	NULL
the	NULL
effects	NULL
of	NULL
NAC	NULL
,	NULL
1	NULL
mM	NULL
BSO	NULL
was	NULL
added	NULL
1	NULL
h	NULL
prior	NULL
the	NULL
addition	NULL
of	NULL
NAC	NULL
.	NULL

For	NULL
experiments	NULL
assessing	NULL
the	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
DC	NULL
maturation	NULL
,	NULL
DC	NULL
were	NULL
incubated	NULL
during	NULL
24	NULL
h	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
ng/ml	NULL
LPS	NULL
or	NULL
during	NULL
72	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mouse	NULL
fibroblasts	NULL
transfected	NULL
with	NULL
the	NULL
human	NULL
CD40	NULL
ligand	NULL
(	NULL
CD40L	NULL
)	NULL
gene	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr.	NULL
Kris	NULL
Thielemans	NULL
,	NULL
Vrije	NULL
Universiteit	NULL
Brussel	NULL
,	NULL
Belgium	NULL
)	NULL
together	NULL
with	NULL
NAC	NULL
.	NULL

After	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
phenotypic	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
supernatants	NULL
were	NULL
harvested	NULL
for	NULL
determination	NULL
of	NULL
cytokine	NULL
levels	NULL
by	NULL
ELISA	NULL
.	NULL

T	NULL
cell	NULL
stimulation	NULL
A	NULL
total	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
purified	NULL
T	NULL
cells	NULL
or	NULL
naive	NULL
CD4SRA	NULL
*	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
a	NULL
96-well	NULL
plate	NULL
either	NULL
by	NULL
7	NULL
X	NULL
10°	NULL
allogenic	NULL
irradiated	NULL
DC	NULL
(	NULL
DC	NULL
:	NULL
T	NULL
ratio	NULL
of	NULL
1:30	NULL
)	NULL
or	NULL
by	NULL
coated	NULL
OKT3	NULL
mAb	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
(	NULL
Ortho	NULL
Biotech	NULL
,	NULL
Raritan	NULL
,	NULL
NJ	NULL
)	NULL
plus	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
1	NULL
pg/ml	NULL
;	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
NAC	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
APC-dependent	NULL
vs	NULL
APC-independent	NULL
stimulation	NULL
of	NULL
purified	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
first	NULL
experiments	NULL
using	NULL
purified	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
tested	NULL
increasing	NULL
doses	NULL
of	NULL
NAC	NULL
in	NULL
stimulation	NULL
experiments	NULL
conducted	NULL
during	NULL
3	NULL
days	NULL
.	NULL

We	NULL
then	NULL
assessed	NULL
the	NULL
effects	NULL
of	NULL
optimal	NULL
concentration	NULL
of	NULL
NAC	NULL
on	NULL
primary	NULL
MLR	NULL
using	NULL
naive	NULL
T	NULL
cells	NULL
during	NULL
various	NULL
incubation	NULL
periods	NULL
.	NULL

After	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
supernatants	NULL
were	NULL
harvested	NULL
for	NULL
determination	NULL
of	NULL
cytokine	NULL
levels	NULL
and	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
was	NULL
added	NULL
during	NULL
8	NULL
h	NULL
to	NULL
assess	NULL
cell	NULL
proliferation	NULL
.	NULL

Cytokine	NULL
assays	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
IL-12	NULL
(	NULL
p40	NULL
)	NULL
were	NULL
measured	NULL
by	NULL
ELISA	NULL
kits	NULL
from	NULL
Biosource	NULL
Europe	NULL
(	NULL
Fleurus	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

IFN-y	NULL
and	NULL
IL-5	NULL
were	NULL
measured	NULL
using	NULL
ELISA	NULL
kits	NULL
from	NULL
Chromogenix	NULL
(	NULL
Mélndal	NULL
,	NULL
Sweden	NULL
)	NULL
and	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Immunophenotyping	NULL
of	NULL
DC	NULL
Cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
BSA	NULL
,	NULL
0.1	NULL
%	NULL
NaN	NULL
,	NULL
10	NULL
%	NULL
pooled	NULL
human	NULL
serum	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
one	NULL
of	NULL
the	NULL
following	NULL
mAbs	NULL
:	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
anti-HLA-DR	NULL
IgG2a	NULL
mAb	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
PE-conjugated	NULL
anti-CD80	NULL
IgG1	NULL
mAb	NULL
(	NULL
B7-1	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
PE-conjugated	NULL
anti-CD86	NULL
(	NULL
B7-2	NULL
)	NULL
IgGZb	NULL
mAb	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
FITC-conjugated	NULL
anti-CD40	NULL
IgG1	NULL
mAb	NULL
(	NULL
Biosource	NULL
International	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
or	NULL
corresponding	NULL
iso-type-matched	NULL
control	NULL
mAbs	NULL
.	NULL

Cell	NULL
fluorescence	NULL
was	NULL
then	NULL
analyzed	NULL
using	NULL
a	NULL
FACScan	NULL
flow-cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Apoptosis	NULL
detection	NULL
A	NULL
total	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
pl	NULL
annexin	NULL
V-FITC	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
Bender	NULL
MedSystems	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
during	NULL
10	NULL
min	NULL
,	NULL
then	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
binding	NULL
buffer	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
5	NULL
pg/ml	NULL
propidium	NULL
iodide	NULL
(	NULL
P1	NULL
)	NULL
.	NULL

Cells	NULL
in	NULL
early	NULL
apoptosis	NULL
(	NULL
annexin	NULL
V-positive	NULL
cells	NULL
)	NULL
,	NULL
cells	NULL
in	NULL
late	NULL
apoptosis	NULL
(	NULL
annexin	NULL
V-positive	NULL
and	NULL
Pl-positive	NULL
)	NULL
,	NULL
and	NULL
necrotic	NULL
cells	NULL
(	NULL
Pl-positive	NULL
cells	NULL
)	NULL
were	NULL
then	NULL
quantified	NULL
by	NULL
FACS	NULL
.	NULL

Mannose	NULL
receptor-mediated	NULL
endocytosis	NULL
evaluation	NULL
DC	NULL
were	NULL
washed	NULL
in	NULL
LPS-free	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
medium	NULL
buffered	NULL
with	NULL
25	NULL
mM	NULL
of	NULL
HEPES	NULL
and	NULL
containing	NULL
0.5	NULL
pg/ml	NULL
FITC-Dextran	NULL
(	NULL
Molecular	NULL
Probe	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

After	NULL
15	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
or	NULL
0°C	NULL
(	NULL
as	NULL
negative	NULL
control	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
cold	NULL
PBS	NULL
prior	NULL
FACS	NULL
analysis	NULL
.	NULL

Cellular	NULL
GSH	NULL
assay	NULL
A	NULL
total	NULL
of	NULL
10°	NULL
DC	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
sonicated	NULL
.	NULL

Proteins	NULL
were	NULL
then	NULL
precipitated	NULL
with	NULL
200	NULL
pl	NULL
metaphosphoric	NULL
acid	NULL
5	NULL
%	NULL
and	NULL
centrifuged	NULL
at	NULL
10,000	NULL
INHIBITORY	NULL
EFFECTS	NULL
OF	NULL
N-ACETYL-L-CYSTEINE	NULL
ON	NULL
HUMAN	NULL
DC	NULL
rpm	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Total	NULL
GSH	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
supernatant	NULL
by	NULL
reduction	NULL
with	NULL
DTT	NULL
,	NULL
derivatization	NULL
with	NULL
monobrobimane	NULL
,	NULL
and	NULL
separation	NULL
by	NULL
HPLC	NULL
(	NULL
adapted	NULL
from	NULL
Ref	NULL
.	NULL

31	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
DC	NULL
were	NULL
incubated	NULL
during	NULL
2	NULL
h	NULL
in	NULL
the	NULL
different	NULL
conditions	NULL
tested	NULL
(	NULL
medium	NULL
alone	NULL
,	NULL
25	NULL
mM	NULL
NAC	NULL
,	NULL
10	NULL
ng/ml	NULL
LPS	NULL
,	NULL
or	NULL
LPS	NULL
plus	NULL
NAC	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
washed	NULL
twice	NULL
in	NULL
cold	NULL
PBS	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspending	NULL
the	NULL
cell	NULL
pellet	NULL
in	NULL
Totex	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
350	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
NP40	NULL
,	NULL
1	NULL
mM	NULL
MgCI2	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
Pefabloc	NULL
,	NULL
5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.15	NULL
IU	NULL
Aprotinin	NULL
)	NULL
during	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
collected	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

NF-KB	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
protein	NULL
extract	NULL
was	NULL
tested	NULL
using	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
murine	NULL
Igx	NULL
enhancer	NULL
that	NULL
had	NULL
the	NULL
following	NULL
se-quence	NULL
:	NULL
5'-AGC	NULL
TAG	NULL
AGG	NULL
GGA	NULL
CTT	NULL
TCC	NULL
GAG	NULL
AGG-3	NULL
'	NULL
and	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
a-*P	NULL
]	NULL
ATP	NULL
by	NULL
using	NULL
Klenow	NULL
enzyme	NULL
(	NULL
Boerhinger	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

For	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
30	NULL
ug	NULL
of	NULL
the	NULL
extract	NULL
were	NULL
added	NULL
to	NULL
a	NULL
reaction	NULL
mixture	NULL
containing	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
20	NULL
ug	NULL
BSA	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
400	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
]	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
10,000	NULL
cpm	NULL
of	NULL
[	NULL
°°P	NULL
]	NULL
-labeled	NULL
oligonucleotide	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
and	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
free	NULL
and	NULL
protein-bound	NULL
oligonucleotides	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
a	NULL
0.5	NULL
%	NULL
Tris-borate	NULL
EDTA	NULL
buffer	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
a	NULL
PhophorImager	NULL
screen	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Statistical	NULL
analysis	NULL
Data	NULL
were	NULL
compared	NULL
using	NULL
the	NULL
nonparametric	NULL
Wilcoxon	NULL
's	NULL
paired	NULL
test	NULL
.	NULL

Results	NULL
NAC	NULL
inhibits	NULL
constitutive	NULL
and	NULL
LPS-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
DC	NULL
As	NULL
DC	NULL
express	NULL
constitutively	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
,	NULL
which	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
many	NULL
genes	NULL
encoding	NULL
immune	NULL
and	NULL
inflammatory	NULL
proteins	NULL
,	NULL
we	NULL
first	NULL
evaluated	NULL
the	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
DC	NULL
both	NULL
at	NULL
the	NULL
basal	NULL
state	NULL
and	NULL
upon	NULL
stimulation	NULL
by	NULL
LPS	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
NAC	NULL
(	NULL
25	NULL
mM	NULL
)	NULL
used	NULL
in	NULL
this	NULL
first	NULL
series	NULL
of	NULL
experiments	NULL
was	NULL
chosen	NULL
according	NULL
to	NULL
previous	NULL
studies	NULL
on	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
1	NULL
,	NULL
5	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
DC	NULL
treatment	NULL
with	NULL
LPS	NULL
clearly	NULL
increased	NULL
the	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
that	NULL
NAC	NULL
inhibited	NULL
the	NULL
constitutive	NULL
as	NULL
well	NULL
as	NULL
the	NULL
LPS-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

Specificity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
established	NULL
using	NULL
excess	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
,	NULL
which	NULL
competed	NULL
successfully	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
,	NULL
while	NULL
a	NULL
nonspecific	NULL
competitor	NULL
(	NULL
AP-1	NULL
probe	NULL
)	NULL
did	NULL
not	NULL
.	NULL

NAC	NULL
down-regulates	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
HLA-DR	NULL
,	NULL
CD86	NULL
(	NULL
B7-2	NULL
)	NULL
,	NULL
and	NULL
CD40	NULL
by	NULL
human	NULL
DC	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
inhibitory	NULL
action	NULL
of	NULL
NAC	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
paralleled	NULL
by	NULL
modifications	NULL
of	NULL
the	NULL
phenotype	NULL
of	NULL
DC	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
surface	NULL
molecules	NULL
involved	NULL
in	NULL
the	NULL
APC	NULL
function	NULL
of	NULL
DC	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
NAC	NULL
clearly	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
HLA-DR	NULL
,	NULL
B7-2	NULL
(	NULL
CD86	NULL
)	NULL
,	NULL
and	NULL
CD40	NULL
,	NULL
while	NULL
leaving	NULL
the	NULL
expression	NULL
of	NULL
B7-1	NULL
(	NULL
CD80	NULL
)	NULL
un-changed	NULL
.	NULL

These	NULL
effects	NULL
of	NULL
NAC	NULL
were	NULL
observed	NULL
in	NULL
presence	NULL
as	NULL
well	NULL
as	NULL
in	NULL
absence	NULL
of	NULL
IL-4	NULL
and	NULL
GM-CSF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NAC	NULL
inhibits	NULL
DC	NULL
responses	NULL
to	NULL
LPS	NULL
or	NULL
CD40	NULL
ligation	NULL
As	NULL
DC	NULL
maturation	NULL
is	NULL
an	NULL
essential	NULL
process	NULL
during	NULL
which	NULL
DC	NULL
acquire	NULL
optimal	NULL
immunostimulatory	NULL
properties	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
influence	NULL
of	NULL
NAC	NULL
on	NULL
DC	NULL
responses	NULL
to	NULL
LPS	NULL
or	NULL
CD40	NULL
ligation	NULL
,	NULL
which	NULL
are	NULL
major	NULL
stimuli	NULL
for	NULL
DC	NULL
maturation	NULL
(	NULL
25-29	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
,	NULL
the	NULL
enhanced	NULL
secretion	NULL
of	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
TNF-a	NULL
induced	NULL
by	NULL
LPS	NULL
was	NULL
inhibited	NULL
by	NULL
NAC	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
;	NULL
a	NULL
maximal	NULL
effect	NULL
was	NULL
achieved	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
25	NULL
mM	NULL
.	NULL

NAC	NULL
also	NULL
inhibited	NULL
CD4O0L-induced	NULL
cytokine	NULL
secretion	NULL
,	NULL
although	NULL
less	NULL
effi-ciently	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
NAC	NULL
simultaneously	NULL
inhibited	NULL
the	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
medium	NULL
LPS	NULL
+	NULL
NAC	NULL
LPS	NULL
+	NULL
cold	NULL
NF-	NULL
«	NULL
xB	NULL
LPS	NULL
+	NULL
cold	NULL
AP-1	NULL
probe	NULL
NAC	NULL
LPS	NULL
NF-	NULL
<	NULL
B	NULL
[	NULL
>	NULL
bo	NULL
n	NULL
t	NULL
on	NULL
(	NULL
0	NULL
FIGURE	NULL
1	NULL
.	NULL

NAC	NULL
inhibits	NULL
the	NULL
basal	NULL
and	NULL
LPS-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

DC	NULL
were	NULL
cultured	NULL
during	NULL
2	NULL
h	NULL
in	NULL
the	NULL
various	NULL
conditions	NULL
tested	NULL
:	NULL
medium	NULL
alone	NULL
,	NULL
NAC	NULL
(	NULL
25	NULL
mM	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
LPS	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
NAC	NULL
(	NULL
25	NULL
mM	NULL
)	NULL
.	NULL

The	NULL
total	NULL
cell	NULL
extract	NULL
was	NULL
assessed	NULL
for	NULL
NF-KB	NULL
binding	NULL
activity	NULL
using	NULL
electorphoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
binding	NULL
,	NULL
100	NULL
%	NULL
excess	NULL
of	NULL
cold	NULL
NF-KB	NULL
or	NULL
cold	NULL
AP-1	NULL
(	NULL
irrelevant	NULL
probe	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
LPS	NULL
condition	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
five	NULL
is	NULL
shown	NULL
.	NULL

HLA-DR	NULL
B	NULL
7	NULL
-	NULL
2	NULL
2571	NULL
up-regulation	NULL
of	NULL
HLA-DR	NULL
,	NULL
B7-2	NULL
,	NULL
and	NULL
CD40	NULL
associated	NULL
with	NULL
LPS-induced	NULL
activation	NULL
.	NULL

The	NULL
induction	NULL
by	NULL
LPS	NULL
of	NULL
CD83	NULL
,	NULL
an	NULL
established	NULL
marker	NULL
of	NULL
DC	NULL
maturation	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
,	NULL
was	NULL
also	NULL
prevented	NULL
by	NULL
NAC	NULL
.	NULL

NAC	NULL
does	NULL
not	NULL
affect	NULL
DC	NULL
viability	NULL
To	NULL
exclude	NULL
a	NULL
cytopathic	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
DC	NULL
,	NULL
we	NULL
first	NULL
evaluated	NULL
DC	NULL
viability	NULL
using	NULL
PI	NULL
and	NULL
annexin	NULL
V	NULL
staining	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
,	NULL
treatment	NULL
of	NULL
DC	NULL
with	NULL
NAC	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
percentages	NULL
of	NULL
apoptotic	NULL
and/or	NULL
necrotic	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
found	NULL
that	NULL
NAC	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
DC	NULL
to	NULL
internalize	NULL
FITC-dextran	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
indicating	NULL
preservation	NULL
of	NULL
their	NULL
ability	NULL
of	NULL
mannose	NULL
receptor-mediated	NULL
endocytosis	NULL
,	NULL
which	NULL
is	NULL
an	NULL
active	NULL
metabolic	NULL
process	NULL
of	NULL
immature	NULL
DC	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NAC	NULL
prevented	NULL
the	NULL
down-regulation	NULL
of	NULL
this	NULL
process	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
DC	NULL
are	NULL
not	NULL
dependent	NULL
of	NULL
an	NULL
increase	NULL
in	NULL
GSH	NULL
cell	NULL
content	NULL
As	NULL
NAC	NULL
can	NULL
act	NULL
both	NULL
through	NULL
its	NULL
scavenging	NULL
properties	NULL
of	NULL
ROI	NULL
and	NULL
as	NULL
a	NULL
precursor	NULL
for	NULL
GSH	NULL
synthesis	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
effects	NULL
of	NULL
NAC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
BSO	NULL
,	NULL
an	NULL
agent	NULL
that	NULL
prevents	NULL
neosynthesis	NULL
of	NULL
GSH	NULL
by	NULL
inhibiting	NULL
the	NULL
y-glutamylcysteine	NULL
synthetase	NULL
(	NULL
34	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
III	NULL
,	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
B7-2	NULL
and	NULL
CD40	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
BSO	NULL
at	NULL
a	NULL
concentration	NULL
preventing	NULL
the	NULL
increase	NULL
in	NULL
GSH	NULL
content	NULL
induced	NULL
by	NULL
NAC	NULL
.	NULL

Similarly	NULL
,	NULL
BSO	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
inhibition	NULL
of	NULL
LPS	NULL
responses	NULL
by	NULL
NAC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NAC	NULL
inhibits	NULL
T	NULL
cell	NULL
responses	NULL
induced	NULL
by	NULL
DC	NULL
but	NULL
not	NULL
by	NULL
APC-independent	NULL
stimuli	NULL
As	NULL
NAC	NULL
down-regulates	NULL
the	NULL
expression	NULL
of	NULL
molecules	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
the	NULL
stimulation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
by	NULL
DC	NULL
and	NULL
renders	NULL
DC	NULL
CD40	NULL
CD83	NULL
100	NULL
Medium	NULL
100	NULL
0	NULL
NAC	NULL
o	NULL
h	NULL
8	NULL
LPS	NULL
sl	NULL
8	NULL
LPS	NULL
+	NULL
NAC	NULL
r	NULL
5p	NULL
3	NULL
EIT	NULL
Log	NULL
Fluorescence	NULL
intensity	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
NAC	NULL
inhibits	NULL
the	NULL
expression	NULL
of	NULL
HLA-DR	NULL
,	NULL
CD86	NULL
(	NULL
B7-2	NULL
)	NULL
,	NULL
and	NULL
CD40	NULL
by	NULL
DC	NULL
.	NULL

DC	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
various	NULL
conditions	NULL
tested	NULL
:	NULL
medium	NULL
alone	NULL
,	NULL
NAC	NULL
(	NULL
25	NULL
mM	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
LPS	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
NAC	NULL
(	NULL
25	NULL
mM	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
after	NULL
staining	NULL
with	NULL
corresponding	NULL
mAbs	NULL
.	NULL

Filled	NULL
histograms	NULL
represent	NULL
isotypic	NULL
control	NULL
staining	NULL
,	NULL
and	NULL
open	NULL
histograms	NULL
represent	NULL
specific	NULL
labeling	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2572	NULL
INHIBITORY	NULL
EFFECTS	NULL
OF	NULL
N-ACETYL-L-CYSTEINE	NULL
ON	NULL
HUMAN	NULL
DC	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
NAC	NULL
inhibits	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
induced	NULL
by	NULL
LPS	NULL
or	NULL
CD4OL®	NULL
IL-6	NULL
(	NULL
ng/ml	NULL
)	NULL
IL-8	NULL
(	NULL
ng/ml	NULL
)	NULL
IL-12	NULL
(	NULL
ng/ml	NULL
)	NULL
TNF-a	NULL
(	NULL
ng/ml	NULL
)	NULL
NAC	NULL
(	NULL
nM	NULL
)	NULL
LPS	NULL
CD40L	NULL
LPS	NULL
CD40L	NULL
LPS	NULL
CD40L	NULL
LPS	NULL
CD40L	NULL
0	NULL
41.8	NULL
+	NULL
15.0	NULL
1.0	NULL
+	NULL
0.4	NULL
67.4	NULL
+	NULL
17.2	NULL
10.9	NULL
+	NULL
4.7	NULL
39.4	NULL
+	NULL
10.6	NULL
18.7	NULL
+	NULL
5.8	NULL
29.4	NULL
+	NULL
5.2	NULL
4.6	NULL
+	NULL
2.3	NULL
3	NULL
40.6	NULL
+	NULL
15.0	NULL
0.6	NULL
+	NULL
0.2	NULL
60.8	NULL
+	NULL
21.5	NULL
6.7	NULL
+	NULL
2.6	NULL
34.2	NULL
+	NULL
11.8	NULL
19.2	NULL
+	NULL
6.4	NULL
23.4	NULL
+	NULL
1.9	NULL
4.4	NULL
+	NULL
2.1	NULL
6	NULL
30.4	NULL
+	NULL
11.0	NULL
0.6	NULL
+	NULL
0.2	NULL
45.4	NULL
+	NULL
9.6	NULL
6.9	NULL
+	NULL
2.6	NULL
28.6	NULL
+	NULL
8.6	NULL
18.7	NULL
+	NULL
5.9	NULL
17.7	NULL
+	NULL
3.1	NULL
3.0	NULL
+	NULL
1.4	NULL
12	NULL
14.5	NULL
+	NULL
4.5	NULL
0.3	NULL
+	NULL
0.1	NULL
26	NULL
+	NULL
4.4	NULL
4.9	NULL
+	NULL
3	NULL
6.7	NULL
+	NULL
24	NULL
17.1	NULL
+	NULL
7.1	NULL
8.5	NULL
+	NULL
1.4	NULL
3.0	NULL
+1	NULL
1.6	NULL
25	NULL
2.9	NULL
+	NULL
0.7	NULL
0.2	NULL
+	NULL
0.1	NULL
4.3	NULL
+	NULL
2.2	NULL
2.5	NULL
+	NULL
1.8	NULL
0.2	NULL
+	NULL
0.1	NULL
5.9	NULL
+	NULL
2.9	NULL
1.4	NULL
+	NULL
0.4	NULL
0.6	NULL
+	NULL
0.2	NULL
``	NULL
DC	NULL
were	NULL
stimulated	NULL
by	NULL
either	NULL
LPS	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
or	NULL
cocultured	NULL
with	NULL
fibroblasts	NULL
transfected	NULL
with	NULL
CD4OL	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
NAC	NULL
.	NULL

Levels	NULL
of	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
TNF-a	NULL
in	NULL
supernatants	NULL
were	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

Basal	NULL
levels	NULL
of	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
TNF-	NULL
@	NULL
were	NULL
0.5	NULL
+	NULL
0.4	NULL
,	NULL
1.3	NULL
+	NULL
0.8	NULL
,	NULL
0.3	NULL
+	NULL
0.1	NULL
,	NULL
and	NULL
0.2	NULL
+	NULL
0.1	NULL
ng/ml	NULL
,	NULL
respectively	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
for	NULL
LPS	NULL
stimulation	NULL
and	NULL
four	NULL
experiments	NULL
for	NULL
CD4OL	NULL
stimulation	NULL
.	NULL

refractory	NULL
to	NULL
maturating	NULL
stimuli	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
T	NULL
cell	NULL
responses	NULL
induced	NULL
either	NULL
by	NULL
allogeneic	NULL
DC	NULL
or	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
Abs	NULL
,	NULL
the	NULL
latter	NULL
activation	NULL
system	NULL
being	NULL
APC-independent	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
increasing	NULL
doses	NULL
of	NULL
NAC	NULL
to	NULL
MLR	NULL
between	NULL
purified	NULL
T	NULL
cells	NULL
and	NULL
irradiated	NULL
allogeneic	NULL
DC	NULL
inhibited	NULL
the	NULL
proliferative	NULL
response	NULL
as	NULL
well	NULL
as	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
and	NULL
IL-5	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
observed	NULL
in	NULL
six	NULL
independent	NULL
experiments	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
beyond	NULL
1.5	NULL
mM	NULL
NAC	NULL
for	NULL
proliferation	NULL
and	NULL
IFN-y	NULL
production	NULL
and	NULL
beyond	NULL
3	NULL
mM	NULL
NAC	NULL
for	NULL
IL-5	NULL
production	NULL
)	NULL
.	NULL

In	NULL
con-trast	NULL
,	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
Abs	NULL
were	NULL
either	NULL
increased	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
for	NULL
IFN-y	NULL
production	NULL
when	NULL
NAC	NULL
is	NULL
added	NULL
at	NULL
concentrations	NULL
ranging	NULL
from	NULL
1.5-12	NULL
mM	NULL
)	NULL
or	NULL
not	NULL
modified	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
NAC	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

To	NULL
further	NULL
document	NULL
the	NULL
action	NULL
of	NULL
NAC	NULL
on	NULL
primary	NULL
T	NULL
cell	NULL
responses	NULL
,	NULL
the	NULL
MLR	NULL
experiments	NULL
were	NULL
repeated	NULL
using	NULL
purified	NULL
naive	NULL
CD45RA	NULL
*	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
as	NULL
responder	NULL
cells	NULL
.	NULL

At	NULL
the	NULL
optimal	NULL
concentration	NULL
of	NULL
NAC	NULL
(	NULL
12	NULL
mM	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
NAC	NULL
profoundly	NULL
inhibited	NULL
the	NULL
T	NULL
cell	NULL
proliferative	NULL
response	NULL
at	NULL
serial	NULL
time	NULL
points	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
secretion	NULL
of	NULL
cytokines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
first	NULL
observed	NULL
that	NULL
NAC	NULL
inhibits	NULL
the	NULL
basal	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
DC	NULL
and	NULL
in	NULL
parallel	NULL
down-regulates	NULL
the	NULL
expression	NULL
of	NULL
surface	NULL
molecules	NULL
known	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
their	NULL
APC	NULL
function	NULL
.	NULL

These	NULL
molecules	NULL
include	NULL
HLA-DR	NULL
involved	NULL
in	NULL
the	NULL
presentation	NULL
of	NULL
antigenic	NULL
peptides	NULL
to	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
B7-2	NULL
,	NULL
a	NULL
costimulatory	NULL
molecule	NULL
acting	NULL
as	NULL
a	NULL
ligand	NULL
for	NULL
CD28	NULL
expressed	NULL
at	NULL
the	NULL
T	NULL
cell	NULL
membrane	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
CD40	NULL
,	NULL
which	NULL
transduces	NULL
activation	NULL
signals	NULL
required	NULL
for	NULL
the	NULL
up-regulation	NULL
of	NULL
B7	NULL
molecules	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
IL-12	NULL
synthesis	NULL
by	NULL
DC	NULL
in	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
confirm	NULL
previous	NULL
observations	NULL
showing	NULL
that	NULL
DC	NULL
express	NULL
constitutively	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
20-24	NULL
)	NULL
and	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
required	NULL
directly	NULL
or	NULL
indirectly	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
their	NULL
function	NULL
.	NULL

Table	NULL
II	NULL
.	NULL

DC	NULL
viability	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
NAC	NULL
``	NULL
Cell	NULL
Labeling	NULL
(	NULL
%	NULL
)	NULL
DC	NULL
Treatment	NULL
Annexin	NULL
V*	NULL
Annexin	NULL
V	NULL
*PI*	NULL
PI+*	NULL
Control	NULL
7.3	NULL
#	NULL
2.1	NULL
11.5	NULL
#	NULL
1.4	NULL
3.1	NULL
£	NULL
0.7	NULL
NAC	NULL
8.9	NULL
+	NULL
2.6	NULL
11.9	NULL
+	NULL
1.7	NULL
3.7	NULL
+	NULL
0.8	NULL
``	NULL
DC	NULL
were	NULL
incubated	NULL
during	NULL
24	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
control	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
mM	NULL
NAC	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
,	NULL
incubated	NULL
with	NULL
annexin	NULL
V-FITC	NULL
followed	NULL
by	NULL
PI	NULL
,	NULL
and	NULL
staining	NULL
was	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Annexin	NULL
V*	NULL
staining	NULL
corresponds	NULL
to	NULL
early	NULL
apoptosis	NULL
,	NULL
annexin	NULL
V	NULL
``	NULL
PI	NULL
*	NULL
staining	NULL
to	NULL
late	NULL
apoptosis	NULL
,	NULL
and	NULL
PI*	NULL
staining	NULL
alone	NULL
to	NULL
necrotic	NULL
cells	NULL
.	NULL

Data	NULL
represent	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
%	NULL
positive	NULL
cells	NULL
in	NULL
each	NULL
quadrant	NULL
of	NULL
a	NULL
dot	NULL
plot	NULL
analysis	NULL
in	NULL
six	NULL
independent	NULL
experiments	NULL
on	NULL
six	NULL
different	NULL
donors	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
NF-KB	NULL
activity	NULL
have	NULL
been	NULL
attributed	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
to	NULL
its	NULL
direct	NULL
scavenging	NULL
properties	NULL
of	NULL
ROI	NULL
and/or	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
alter	NULL
the	NULL
redox	NULL
potential	NULL
of	NULL
the	NULL
cell	NULL
to	NULL
a	NULL
more	NULL
reduced	NULL
one	NULL
,	NULL
either	NULL
directly	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
thiol	NULL
group	NULL
or	NULL
indirectly	NULL
by	NULL
increasing	NULL
the	NULL
synthesis	NULL
of	NULL
GSH	NULL
(	NULL
7-11	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
DC	NULL
are	NULL
not	NULL
due	NULL
to	NULL
a	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
GSH	NULL
as	NULL
they	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
BSO	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
GSH	NULL
synthesis	NULL
.	NULL

Accordingly	NULL
,	NULL
previous	NULL
data	NULL
have	NULL
demonstrated	NULL
similar	NULL
GSH-independent	NULL
inhibitory	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
TNF	NULL
production	NULL
by	NULL
Kupffer	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
on	NULL
HIV	NULL
transcription	NULL
and	NULL
replication	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Maturation	NULL
of	NULL
DC	NULL
is	NULL
a	NULL
critical	NULL
process	NULL
as	NULL
only	NULL
mature	NULL
DC	NULL
are	NULL
able	NULL
to	NULL
induce	NULL
optimal	NULL
activation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

During	NULL
this	NULL
100	NULL
Medium	NULL
100	NULL
0	NULL
NAC	NULL
100	NULL
0	NULL
LPS	NULL
100	NULL
0	NULL
LPS	NULL
+	NULL
NAC	NULL
10	NULL
``	NULL
10	NULL
A	NULL
FL1-H	NULL
10	NULL
1	NULL
10	NULL
FIGURE	NULL
3	NULL
.	NULL

NAC	NULL
inhibits	NULL
the	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
allogeneic	NULL
DC	NULL
but	NULL
not	NULL
by	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
mAbs	NULL
.	NULL

Purified	NULL
T	NULL
lymphocytes	NULL
were	NULL
stimulated	NULL
either	NULL
by	NULL
allogeneic	NULL
DC	NULL
at	NULL
the	NULL
ratio	NULL
of	NULL
1	NULL
DC	NULL
per	NULL
30	NULL
T	NULL
cells	NULL
(	NULL
left	NULL
column	NULL
)	NULL
or	NULL
by	NULL
coated	NULL
anti-CD3	NULL
(	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

plus	NULL
anti-CD28	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
mAbs	NULL
in	NULL
presence	NULL
of	NULL
increasing	NULL
doses	NULL
of	NULL
NAC	NULL
(	NULL
right	NULL
column	NULL
)	NULL
.	NULL

After	NULL
3	NULL
days	NULL
,	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
for	NULL
IL-5	NULL
and	NULL
IFN-y	NULL
determination	NULL
by	NULL
ELISA	NULL
,	NULL
and	NULL
T	NULL
cell	NULL
proliferation	NULL
was	NULL
measured	NULL
by	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
six	NULL
is	NULL
shown	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
€	NULL
T+	NULL
DC	NULL
T	NULL
+	NULL
a-CD3	NULL
+	NULL
a-CD28	NULL
g25	NULL
150	NULL
T	NULL
@	NULL
7	NULL
é	NULL
220	NULL
1	NULL
120	NULL
M	NULL
-	NULL
8	NULL
,	NULL
I	NULL
§10	NULL
|	NULL
60	NULL
*	NULL
g	NULL
g	NULL
s	NULL
|	NULL
30	NULL
£	NULL
0	NULL
1	NULL
i	NULL
+	NULL
I	NULL
0	NULL
4	NULL
t	NULL
1	NULL
4	NULL
|	NULL
180	NULL
|	NULL
,	NULL
5000	NULL
a	NULL
120	NULL
+	NULL
4000	NULL
ZH—A	NULL
£	NULL
3	NULL
90	NULL
;	NULL
F	NULL
3	NULL
e0	NULL
|	NULL
&	NULL
30	NULL
+	NULL
0	NULL
1	NULL
+	NULL
100	NULL
~	NULL
80	NULL
2	NULL
200	NULL
&	NULL
so	NULL
&	NULL
e00	NULL
w	NULL
40	NULL
|	NULL
[	NULL
o	NULL
--	NULL
0	NULL
1,6	NULL
3	NULL
60	NULL
12	NULL
NAC	NULL
(	NULL
mM	NULL
)	NULL
FIGURE	NULL
4	NULL
.	NULL

Mannose	NULL
receptor-	NULL
mediated	NULL
endocytosis	NULL
of	NULL
DC	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
NAC	NULL
.	NULL

DC	NULL
were	NULL
cultured	NULL
during	NULL
24	NULL
h	NULL
in	NULL
the	NULL
various	NULL
conditions	NULL
tested	NULL
:	NULL
medium	NULL
alone	NULL
,	NULL
NAC	NULL
(	NULL
25	NULL
mM	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
LPS	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
plus	NULL
NAC	NULL
(	NULL
25	NULL
mM	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
in	NULL
cold	NULL
PBS	NULL
,	NULL
FITC-dextran	NULL
internal-ization	NULL
by	NULL
DC	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Dotted	NULL
lines	NULL
represent	NULL
negative	NULL
control	NULL
at	NULL
0°C	NULL
,	NULL
and	NULL
thick	NULL
lines	NULL
represent	NULL
phagocytosis	NULL
at	NULL
37°C	NULL
.	NULL

Numbers	NULL
represent	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
that	NULL
have	NULL
internalized	NULL
FITC-dextran	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

process	NULL
,	NULL
DC	NULL
lose	NULL
their	NULL
ability	NULL
to	NULL
capture	NULL
and	NULL
process	NULL
Ags	NULL
,	NULL
increase	NULL
their	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
and	NULL
costimulatory	NULL
molecules	NULL
,	NULL
and	NULL
up-regulate	NULL
their	NULL
production	NULL
of	NULL
cytokines	NULL
(	NULL
25-29	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
maturation	NULL
is	NULL
closely	NULL
associated	NULL
with	NULL
surface	NULL
expression	NULL
of	NULL
CD83	NULL
,	NULL
the	NULL
function	NULL
of	NULL
which	NULL
is	NULL
still	NULL
unknown	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
schemat-ically	NULL
,	NULL
maturation	NULL
of	NULL
DC	NULL
is	NULL
initiated	NULL
in	NULL
nonlymphoid	NULL
tissues	NULL
upon	NULL
exposure	NULL
to	NULL
inflammatory	NULL
molecules	NULL
such	NULL
as	NULL
LPS	NULL
and	NULL
is	NULL
achieved	NULL
in	NULL
lymph	NULL
nodes	NULL
upon	NULL
CD40	NULL
engagement	NULL
by	NULL
CD4OL-expressing	NULL
T	NULL
cells	NULL
.	NULL

NAC	NULL
was	NULL
found	NULL
to	NULL
strongly	NULL
inhibit	NULL
DC	NULL
maturation	NULL
as	NULL
reflected	NULL
by	NULL
its	NULL
inhibitory	NULL
effects	NULL
on	NULL
cytokine	NULL
synthesis	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
,	NULL
B7-2	NULL
,	NULL
and	NULL
CD40	NULL
up-regulation	NULL
,	NULL
induction	NULL
of	NULL
CD83	NULL
expression	NULL
,	NULL
and	NULL
down-regulation	NULL
of	NULL
mannose	NULL
receptor-mediated	NULL
endocytosis	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
LPS-induced	NULL
maturation	NULL
of	NULL
DC	NULL
was	NULL
associated	NULL
with	NULL
increased	NULL
activity	NULL
of	NULL
NF-KB	NULL
and	NULL
that	NULL
NAC	NULL
also	NULL
inhibited	NULL
this	NULL
effect	NULL
of	NULL
LPS	NULL
on	NULL
DC	NULL
.	NULL

Finally	NULL
,	NULL
NAC	NULL
did	NULL
also	NULL
inhibit	NULL
the	NULL
effects	NULL
of	NULL
CD40	NULL
engagement	NULL
on	NULL
the	NULL
stimulation	NULL
of	NULL
cytokine	NULL
production	NULL
and	NULL
costimulatory	NULL
molecule	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
relevance	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
DC	NULL
was	NULL
established	NULL
during	NULL
MLR	NULL
experiments	NULL
in	NULL
which	NULL
we	NULL
observed	NULL
that	NULL
NAC	NULL
inhibits	NULL
the	NULL
ability	NULL
of	NULL
DC	NULL
to	NULL
stimulate	NULL
alloreactive	NULL
Table	NULL
III	NULL
.	NULL

-	NULL
The	NULL
effects	NULL
of	NULL
NAC	NULL
on	NULL
DC	NULL
are	NULL
not	NULL
dependent	NULL
of	NULL
increased	NULL
intracellular	NULL
GSH*	NULL
DC	NULL
Treatment	NULL
B7-2	NULL
CD40	NULL
GSH	NULL
Content	NULL
Control	NULL
51.3	NULL
+	NULL
12	NULL
98.3	NULL
+	NULL
18.8	NULL
4.4	NULL
+	NULL
0.4	NULL
NAC	NULL
5.7	NULL
*	NULL
2	NULL
11.3	NULL
+	NULL
2.8	NULL
8.6	NULL
+	NULL
1.5	NULL
NAC+BSO	NULL
6.4	NULL
+	NULL
2	NULL
114	NULL
+	NULL
2.1	NULL
4.2	NULL
+	NULL
1	NULL
BSO	NULL
57.3	NULL
+	NULL
14.5	NULL
111.6	NULL
+	NULL
24.5	NULL
2.1	NULL
+	NULL
0.4	NULL
``	NULL
A	NULL
total	NULL
of	NULL
10°	NULL
DC	NULL
were	NULL
incubated	NULL
during	NULL
24	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
mM	NULL
NAC	NULL
,	NULL
NAC	NULL
plus	NULL
1	NULL
mM	NULL
BSO	NULL
,	NULL
or	NULL
BSO	NULL
alone	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
B7-2	NULL
and	NULL
CD40	NULL
was	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
expressed	NULL
as	NULL
medium	NULL
of	NULL
fluorescence	NULL
intensity	NULL
.	NULL

Cellular	NULL
GSH	NULL
content	NULL
was	NULL
determined	NULL
by	NULL
HPLC	NULL
after	NULL
sonication	NULL
and	NULL
protein	NULL
precipitation	NULL
and	NULL
is	NULL
expressed	NULL
in	NULL
nmol/10®	NULL
DC	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

2573	NULL
120	NULL
a	NULL
Onaive	NULL
T	NULL
+	NULL
DC	NULL
3	NULL
&	NULL
3	NULL
,	NULL
100	NULL
+	NULL
|	NULL
Minaive	NULL
T	NULL
+	NULL
DC	NULL
+	NULL
NAC	NULL
3	NULL
3	NULL
§€591	NULL
0	NULL
a	NULL
|	NULL
s	NULL
0	NULL
sys	NULL
G	NULL
%	NULL
|	NULL
E	NULL
40	NULL
J	NULL
£	NULL
i	NULL
£	NULL
20	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
Time	NULL
(	NULL
days	NULL
)	NULL
FIGURE	NULL
5	NULL
.	NULL

NAC	NULL
inhibits	NULL
the	NULL
stimulation	NULL
of	NULL
naive	NULL
CDASRA*	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Naive	NULL
CD4SRA	NULL
*	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
allogeneic	NULL
DC	NULL
at	NULL
the	NULL
ratio	NULL
of	NULL
1	NULL
DC	NULL
per	NULL
30	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
NAC	NULL
(	NULL
12	NULL
mM	NULL
)	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NAC	NULL
.	NULL

After	NULL
various	NULL
times	NULL
,	NULL
T	NULL
cells	NULL
proliferation	NULL
was	NULL
assessed	NULL
by	NULL
incorporation	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
four	NULL
is	NULL
shown	NULL
.	NULL

T	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
T	NULL
cell	NULL
proliferative	NULL
responses	NULL
as	NULL
well	NULL
as	NULL
the	NULL
synthesis	NULL
of	NULL
cytokines	NULL
of	NULL
both	NULL
Th1-type	NULL
(	NULL
IFN-y	NULL
)	NULL
and	NULL
Th2-type	NULL
(	NULL
IL-5	NULL
)	NULL
were	NULL
decreased	NULL
by	NULL
NAC	NULL
.	NULL

The	NULL
suppressive	NULL
effect	NULL
of	NULL
NAC	NULL
was	NULL
especially	NULL
pronounced	NULL
when	NULL
naive	NULL
CD4SRA	NULL
*	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
responder	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
is	NULL
strongly	NULL
dependent	NULL
on	NULL
costimulatory	NULL
signals	NULL
delivered	NULL
by	NULL
DC	NULL
(	NULL
18	NULL
,	NULL
19	NULL
,	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Peterson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
recently	NULL
showed	NULL
that	NULL
GSH	NULL
depletion	NULL
of	NULL
murine	NULL
spleen	NULL
cells	NULL
inhibits	NULL
their	NULL
ability	NULL
to	NULL
elicit	NULL
Th1-type	NULL
responses	NULL
while	NULL
favoring	NULL
Th2-type	NULL
responses	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
GSH	NULL
depletion	NULL
in	NULL
this	NULL
model	NULL
are	NULL
due	NULL
to	NULL
its	NULL
action	NULL
on	NULL
other	NULL
APC	NULL
than	NULL
DC	NULL
.	NULL

Moreover	NULL
,	NULL
GSH	NULL
depletion	NULL
should	NULL
not	NULL
be	NULL
considered	NULL
as	NULL
a	NULL
mirror	NULL
of	NULL
NAC	NULL
treatment	NULL
as	NULL
certain	NULL
effects	NULL
of	NULL
NAC	NULL
do	NULL
not	NULL
involve	NULL
GSH	NULL
replenishment	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
already	NULL
mentioned	NULL
,	NULL
the	NULL
deactivating	NULL
effects	NULL
of	NULL
NAC	NULL
in	NULL
DC	NULL
,	NULL
but	NULL
also	NULL
in	NULL
other	NULL
systems	NULL
(	NULL
4	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
,	NULL
were	NULL
found	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
an	NULL
increase	NULL
in	NULL
intracellular	NULL
GSH	NULL
.	NULL

Our	NULL
data	NULL
corroborate	NULL
previous	NULL
observations	NULL
made	NULL
by	NULL
Chaudhri	NULL
et	NULL
al	NULL
.	NULL

(	NULL
43	NULL
)	NULL
indicating	NULL
that	NULL
different	NULL
types	NULL
of	NULL
antioxidants	NULL
inhibited	NULL
primary	NULL
alloantigen-induced	NULL
T	NULL
cell	NULL
responses	NULL
,	NULL
although	NULL
the	NULL
influence	NULL
of	NULL
these	NULL
compounds	NULL
at	NULL
the	NULL
DC	NULL
level	NULL
was	NULL
not	NULL
considered	NULL
in	NULL
this	NULL
mouse	NULL
model	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
clearly	NULL
established	NULL
that	NULL
T	NULL
cell	NULL
hyporespon-siveness	NULL
observed	NULL
in	NULL
various	NULL
conditions	NULL
including	NULL
AIDS	NULL
(	NULL
4	NULL
,	NULL
6	NULL
)	NULL
,	NULL
common	NULL
variable	NULL
immunodeficiency	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
ageing	NULL
(	NULL
44	NULL
)	NULL
are	NULL
related	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
T	NULL
cell	NULL
GSH	NULL
content	NULL
,	NULL
leading	NULL
to	NULL
propose	NULL
GSH	NULL
supplementation	NULL
using	NULL
NAC	NULL
to	NULL
enhance	NULL
immune	NULL
functions	NULL
in	NULL
these	NULL
disorders	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
NAC	NULL
inhibits	NULL
primary	NULL
human	NULL
T	NULL
cell	NULL
responses	NULL
elicited	NULL
by	NULL
DC	NULL
indicates	NULL
that	NULL
this	NULL
drug	NULL
should	NULL
be	NULL
considered	NULL
as	NULL
a	NULL
double-edged	NULL
sword	NULL
when	NULL
administered	NULL
to	NULL
immuno-deficient	NULL
patients	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
immu-nosuppressive	NULL
effects	NULL
of	NULL
NAC	NULL
at	NULL
the	NULL
DC	NULL
level	NULL
might	NULL
be	NULL
exploited	NULL
to	NULL
prevent	NULL
pathogenic	NULL
immune	NULL
responses	NULL
such	NULL
as	NULL
allograft	NULL
rejection	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
D.	NULL
Mercan	NULL
for	NULL
GSH	NULL
determinations	NULL
,	NULL
A.	NULL
Crusiaux	NULL
for	NULL
cytokine	NULL
measurements	NULL
,	NULL
and	NULL
Adrienne	NULL
Scheich	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
M.	NULL
Roederer	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

Intracellular	NULL
thiols	NULL
regulate	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
B	NULL
and	NULL
transcription	NULL
of	NULL
human	NULL
deficiency	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9943	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2574	NULL
2	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
J.	NULL
Staal	NULL
,	NULL
P.	NULL
A.	NULL
Raju	NULL
,	NULL
S.	NULL
W.	NULL
Ela	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

Cytokine-stimulated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
is	NULL
inhibited	NULL
by	NULL
N-acetyl-L-cysteine	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4884.	NULL
.	NULL

Kalebic	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
M.	NULL
E.	NULL
Anderson	NULL
,	NULL
A.	NULL
Meister	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1991	NULL
.	NULL

Suppression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
in	NULL
chronically	NULL
infected	NULL
monocytic	NULL
cells	NULL
by	NULL
glutathione	NULL
,	NULL
glutathione	NULL
ester	NULL
,	NULL
and	NULL
N-acetylcysteine	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:986.	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
S.	NULL
W.	NULL
Ela	NULL
,	NULL
M.	NULL
Roederer	NULL
,	NULL
M.	NULL
T.	NULL
Anderson	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1992	NULL
.	NULL

Glutathione	NULL
deficiency	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
.	NULL

Lancet	NULL
339:909	NULL
,	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Ricber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:2247.	NULL
.	NULL

Droge	NULL
,	NULL
W.	NULL
,	NULL
H.	NULL
P.	NULL
Eck	NULL
,	NULL
and	NULL
S.	NULL
Mihm	NULL
.	NULL

1992	NULL
.	NULL

HIV-induced	NULL
cysteine	NULL
deficiency	NULL
and	NULL
T-cell	NULL
dysfunction-a	NULL
rationale	NULL
for	NULL
treatment	NULL
with	NULL
N-acetylcysteine	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:211-214.	NULL
.	NULL

Winyard	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Blake	NULL
.	NULL

1997	NULL
.	NULL

Antioxidants	NULL
,	NULL
redox-regulated	NULL
transcrip-	NULL
tion	NULL
factors	NULL
,	NULL
and	NULL
inflammation	NULL
.	NULL

Adv	NULL
.	NULL

Pharmacol	NULL
.	NULL

38:403.	NULL
.	NULL

Cotgreave	NULL
,	NULL
I	NULL
.	NULL

A	NULL
.	NULL

1997	NULL
.	NULL

N-acetylcysteine	NULL
:	NULL
pharmacological	NULL
considerations	NULL
and	NULL
ex	NULL
perimental	NULL
and	NULL
clinical	NULL
applications	NULL
.	NULL

Adv	NULL
.	NULL

Pharmacol	NULL
.	NULL

38:205.	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anru	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Albermann	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
kB	NULL
:	NULL
an	NULL
oxidative	NULL
stress	NULL
responsive	NULL
transcription	NULL
factor	NULL
of	NULL
eukaryotic	NULL
cells	NULL
(	NULL
a	NULL
review	NULL
)	NULL
.	NULL

Free	NULL
Radical	NULL
Res	NULL
.	NULL

Comm	NULL
.	NULL

17:221	NULL
.	NULL

Flohe	NULL
,	NULL
L.	NULL
,	NULL
R.	NULL
Brigelius	NULL
Flohe	NULL
,	NULL
C.	NULL
Saliou	NULL
,	NULL
M.	NULL
G.	NULL
Traber	NULL
,	NULL
and	NULL
L.	NULL
Packer	NULL
.	NULL

1997	NULL
.	NULL

Redox	NULL
regulation	NULL
of	NULL
NF-KB	NULL
activation	NULL
.	NULL

Free	NULL
Radical	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

22:1115	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
M.	NULL
T.	NULL
Anderson	NULL
,	NULL
G.	NULL
R.	NULL
J.	NULL
Staal	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
C.	NULL
Gitler	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1994	NULL
.	NULL

Redox	NULL
regulation	NULL
of	NULL
signal	NULL
transduction	NULL
:	NULL
tyrosine	NULL
phos-phorylation	NULL
and	NULL
calcium	NULL
influx	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3619	NULL
.	NULL

Suthanthiran	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
E.	NULL
Anderson	NULL
,	NULL
V.	NULL
K.	NULL
Sharma	NULL
,	NULL
and	NULL
A.	NULL
Meister	NULL
.	NULL

1990	NULL
.	NULL

Glutathione	NULL
regulates	NULL
activation-dependent	NULL
DNA	NULL
synthesis	NULL
in	NULL
highly	NULL
purified	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
via	NULL
the	NULL
CD2	NULL
and	NULL
CD3	NULL
antigens	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:3343	NULL
.	NULL

Smyth	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Glutathione	NULL
modulates	NULL
activation-dependent	NULL
proliferation	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
populations	NULL
without	NULL
regulating	NULL
their	NULL
activated	NULL
function	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1921	NULL
.	NULL

Eylar	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Rivera-Quinones	NULL
,	NULL
C.	NULL
Molina	NULL
,	NULL
I.	NULL
Baez	NULL
,	NULL
F.	NULL
Molina	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Mercado	NULL
.	NULL

1993	NULL
.	NULL

N-Acetylcysteine	NULL
enhances	NULL
T	NULL
cell	NULL
functions	NULL
and	NULL
T	NULL
cell	NULL
growth	NULL
in	NULL
culture	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

5:97	NULL
.	NULL

Jeannin	NULL
,	NULL
P.	NULL
,	NULL
Y.	NULL
Delneste	NULL
,	NULL
S.	NULL
Lecoanet-Henchoz	NULL
,	NULL
J.	NULL
Gauchat	NULL
,	NULL
P.	NULL
Life	NULL
,	NULL
D.	NULL
Holmes	NULL
,	NULL
and	NULL
J.	NULL
Bonnefoy	NULL
.	NULL

1995	NULL
.	NULL

Thiols	NULL
decrease	NULL
human	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
4	NULL
production	NULL
and	NULL
TL-4-induced	NULL
immunoglobulin	NULL
synthesis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1785	NULL
.	NULL

Aukrust	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Svardal	NULL
,	NULL
F.	NULL
Miller	NULL
,	NULL
B.	NULL
Lunden	NULL
,	NULL
R.	NULL
K.	NULL
Berge	NULL
,	NULL
and	NULL
S.	NULL
S.	NULL
Froland	NULL
.	NULL

1995	NULL
.	NULL

Decreased	NULL
levels	NULL
of	NULL
total	NULL
and	NULL
reduced	NULL
glutathione	NULL
in	NULL
CD4	NULL
*	NULL
lymphocytes	NULL
in	NULL
common	NULL
variable	NULL
immunodeficiency	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
system	NULL
:	NULL
possible	NULL
immunopathogenic	NULL
role	NULL
of	NULL
oxidative	NULL
stress	NULL
.	NULL

Blood	NULL
86:1383	NULL
.	NULL

Steinman	NULL
,	NULL
R.	NULL
M.	NULL
1991	NULL
.	NULL

The	NULL
dendritic	NULL
cell	NULL
system	NULL
and	NULL
its	NULL
role	NULL
in	NULL
immunogenicity	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9:271	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1998	NULL
.	NULL

Dendritic	NULL
cells	NULL
and	NULL
the	NULL
control	NULL
of	NULL
immunity	NULL
.	NULL

Nature	NULL
392:245	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Korner	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
J.	NULL
Vassy	NULL
,	NULL
and	NULL
M.	NULL
Raphael	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
nuclear	NULL
localization	NULL
of	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
RelB	NULL
proteins	NULL
in	NULL
human	NULL
accessory	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
in	NULL
situ	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:2547	NULL
.	NULL

Pettit	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
C.	NULL
Quinn	NULL
,	NULL
K.	NULL
P.	NULL
A.	NULL
MacDonald	NULL
,	NULL
L.	NULL
L.	NULL
Cavanagh	NULL
,	NULL
G.	NULL
Thomas	NULL
,	NULL
W.	NULL
Townsend	NULL
,	NULL
M.	NULL
Handel	NULL
,	NULL
and	NULL
R.	NULL
Thomas	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
localisation	NULL
of	NULL
ReIB	NULL
is	NULL
associated	NULL
with	NULL
effective	NULL
antigen-presenting	NULL
cell	NULL
function	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3681	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Pope	NULL
,	NULL
K.	NULL
Inaba	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1995	NULL
.	NULL

Coexpres-sion	NULL
of	NULL
NF-	NULL
«	NULL
B/rel	NULL
and	NULL
Spl	NULL
transcription	NULL
factors	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
l-induced	NULL
,	NULL
dendritic	NULL
cell-T-cell	NULL
syncitia	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
:	NULL
10944	NULL
.	NULL

Preisch1	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
G.	NULL
G.	NULL
Pendl	NULL
,	NULL
A.	NULL
Elbe	NULL
,	NULL
E.	NULL
Serfling	NULL
,	NULL
N.	NULL
E.	NULL
Harrer	NULL
,	NULL
G.	NULL
Stingl	NULL
,	NULL
and	NULL
T.	NULL
Baumruker	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
in	NULL
the	NULL
murine	NULL
dendritic	NULL
cell	NULL
line	NULL
18	NULL
and	NULL
the	NULL
murine	NULL
mast	NULL
cell	NULL
line	NULL
CPL	NULL
is	NULL
differently	NULL
regulated	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:2645	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

INHIBITORY	NULL
EFFECTS	NULL
OF	NULL
N-ACETYL-L-CYSTEINE	NULL
ON	NULL
HUMAN	NULL
DC	NULL
Oyama	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Ran	NULL
,	NULL
T.	NULL
Ishida	NULL
,	NULL
L.	NULL
Kerr	NULL
,	NULL
D.	NULL
P.	NULL
Carbone	NULL
,	NULL
and	NULL
D.	NULL
I.	NULL
Gabrilovich	NULL
.	NULL

1998	NULL
.	NULL

Vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
affects	NULL
dendritic	NULL
cell	NULL
maturation	NULL
through	NULL
the	NULL
inhibition	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
hemopocitic	NULL
progenitor	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:1224	NULL
.	NULL

Sallusto	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Cella	NULL
,	NULL
C.	NULL
Danieli	NULL
,	NULL
and	NULL
A.	NULL
Lanzavecchia	NULL
.	NULL

1995	NULL
.	NULL

Dendritic	NULL
cells	NULL
use	NULL
macropinocytosis	NULL
and	NULL
the	NULL
mannose	NULL
receptor	NULL
to	NULL
concentrate	NULL
macromolecules	NULL
in	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
compartment	NULL
:	NULL
downregulation	NULL
by	NULL
cytokines	NULL
and	NULL
microbial	NULL
products	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:389	NULL
.	NULL

Caux	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Massacrier	NULL
,	NULL
B.	NULL
Vanbervliet	NULL
,	NULL
B.	NULL
Dubois	NULL
,	NULL
C.	NULL
Van	NULL
Kooten	NULL
,	NULL
I.	NULL
Durand	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
dendritic	NULL
cells	NULL
by	NULL
CD40	NULL
cross-linking	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1263	NULL
.	NULL

Verhasselt	NULL
,	NULL
V.	NULL
,	NULL
C.	NULL
Buclens	NULL
,	NULL
F.	NULL
Willems	NULL
,	NULL
D.	NULL
De	NULL
Groote	NULL
,	NULL
N.	NULL
Haeffner	NULL
Cavaillon	NULL
,	NULL
and	NULL
M.	NULL
Goldman	NULL
.	NULL

1997	NULL
.	NULL

Bacterial	NULL
lipopolysaccharide	NULL
stimulates	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
costimulatory	NULL
molecules	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
dendritic	NULL
cells	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
soluble	NULL
CD14-dependent	NULL
pathway	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:2919	NULL
.	NULL

De	NULL
Smedt	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Pajak	NULL
,	NULL
E.	NULL
Muraille	NULL
,	NULL
E.	NULL
Heinen	NULL
,	NULL
P.	NULL
De	NULL
Bactselier	NULL
,	NULL
J.	NULL
Urbain	NULL
,	NULL
O.	NULL
Leo	NULL
,	NULL
and	NULL
M.	NULL
Moser	NULL
.	NULL

1996	NULL
.	NULL

Lipopolysaccharide	NULL
induces	NULL
intrasplenic	NULL
migration	NULL
and	NULL
functional	NULL
maturation	NULL
of	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1413	NULL
.	NULL

Cella	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Scheidegger	NULL
,	NULL
K.	NULL
Palmer	NULL
Lehmann	NULL
,	NULL
P.	NULL
Lane	NULL
,	NULL
A.	NULL
Lanzavecchia	NULL
,	NULL
and	NULL
G.	NULL
Alber	NULL
.	NULL

1996	NULL
.	NULL

Ligation	NULL
of	NULL
CD40	NULL
on	NULL
dendritic	NULL
cells	NULL
triggers	NULL
production	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
interleukin-12	NULL
and	NULL
enhances	NULL
T	NULL
cell	NULL
stimulatory	NULL
capacity	NULL
:	NULL
T-T	NULL
help	NULL
via	NULL
APC	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:747	NULL
.	NULL

Romani	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Gruner	NULL
,	NULL
D.	NULL
Brang	NULL
,	NULL
E.	NULL
Kiimpgen	NULL
,	NULL
A.	NULL
Lenz	NULL
,	NULL
B.	NULL
Trockenbacker	NULL
,	NULL
G.	NULL
Konwalinka	NULL
,	NULL
P.	NULL
O.	NULL
Fritsch	NULL
,	NULL
R.	NULL
M.	NULL
Steinman	NULL
,	NULL
and	NULL
G.	NULL
Schuler	NULL
.	NULL

1994	NULL
.	NULL

Proliferating	NULL
dendritic	NULL
cell	NULL
progenitors	NULL
in	NULL
human	NULL
blood	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:83	NULL
.	NULL

Svardal	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
M.	NULL
A.	NULL
Mansoor	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Ueland	NULL
.	NULL

1990	NULL
.	NULL

Determination	NULL
of	NULL
reduced	NULL
,	NULL
oxidized	NULL
,	NULL
and	NULL
protein-bound	NULL
glutathione	NULL
in	NULL
human	NULL
plasma	NULL
with	NULL
precol-umn	NULL
derivatization	NULL
with	NULL
monobromobimane	NULL
and	NULL
liquid	NULL
chromatography	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

184:338	NULL
.	NULL

Zhou	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
.	NULL

1996	NULL
.	NULL

CD14*	NULL
blood	NULL
monocytes	NULL
can	NULL
differentiate	NULL
into	NULL
functionally	NULL
mature	NULL
CD83*	NULL
dendritic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:2588	NULL
.	NULL

Zhou	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
blood	NULL
dendritic	NULL
cells	NULL
selectively	NULL
express	NULL
CD83	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
superfamily	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154	NULL
:	NULL
3821	NULL
.	NULL

Griffith	NULL
,	NULL
O.	NULL
W.	NULL
1982	NULL
.	NULL

Mechanism	NULL
of	NULL
action	NULL
,	NULL
metabolism	NULL
,	NULL
and	NULL
toxicity	NULL
of	NULL
buthi-onine	NULL
sulfoximine	NULL
and	NULL
its	NULL
higher	NULL
homologs	NULL
,	NULL
potent	NULL
inhibitors	NULL
of	NULL
glutathione	NULL
synthesis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

257:13704	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

€CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:233.	NULL
van	NULL
Kooten	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1997	NULL
.	NULL

Functions	NULL
of	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
,	NULL
dendritic	NULL
cells	NULL
and	NULL
other	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:330	NULL
.	NULL

Grewal	NULL
,	NULL
I.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
central	NULL
role	NULL
of	NULL
CD40	NULL
ligand	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD4*	NULL
T-cell	NULL
responses	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:410	NULL
.	NULL

Neuschwander	NULL
Tetri	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
M.	NULL
Bellezzo	NULL
,	NULL
R.	NULL
S.	NULL
Britton	NULL
,	NULL
B.	NULL
R.	NULL
Bacon	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Fox	NULL
.	NULL

1996	NULL
.	NULL

Thiol	NULL
regulation	NULL
of	NULL
endotoxin-induced	NULL
release	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor	NULL
a	NULL
from	NULL
isolated	NULL
rat	NULL
Kupffer	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

320:1005	NULL
.	NULL

Mihm	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Ennen	NULL
,	NULL
U.	NULL
Pessara	NULL
,	NULL
R.	NULL
Kurth	NULL
,	NULL
and	NULL
W.	NULL
Droge	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
HIV-1	NULL
replication	NULL
and	NULL
NF-KB	NULL
activity	NULL
by	NULL
cysteine	NULL
and	NULL
cysteine	NULL
derivatives	NULL
.	NULL

AIDS	NULL
5:497-503	NULL
.	NULL

Croft	NULL
,	NULL
M.	NULL
1994	NULL
.	NULL

Activation	NULL
of	NULL
naive	NULL
,	NULL
memory	NULL
and	NULL
effector	NULL
T	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6:431	NULL
.	NULL

Croft	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
M.	NULL
Bradley	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Swain	NULL
.	NULL

1994	NULL
.	NULL

Naive	NULL
versus	NULL
memory	NULL
CD4	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
antigen	NULL
:	NULL
memory	NULL
cells	NULL
are	NULL
less	NULL
dependent	NULL
on	NULL
accessory	NULL
cell	NULL
co-stimulation	NULL
and	NULL
can	NULL
respond	NULL
to	NULL
many	NULL
antigen-presenting	NULL
cell	NULL
types	NULL
including	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:2675	NULL
.	NULL

Peterson	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
K.	NULL
Vasquez	NULL
,	NULL
and	NULL
C.	NULL
Waltenbaugh	NULL
.	NULL

1998	NULL
.	NULL

Glutathione	NULL
levels	NULL
in	NULL
antigen-presenting	NULL
cells	NULL
modulate	NULL
Th1	NULL
versus	NULL
Th2	NULL
response	NULL
patterns	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:3071	NULL
.	NULL

Chaudhri	NULL
,	NULL
G.	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Clark	NULL
,	NULL
N.	NULL
H.	NULL
Hunt	NULL
,	NULL
W.	NULL
B.	NULL
Cowden	NULL
,	NULL
and	NULL
R.	NULL
Ceredig	NULL
.	NULL

1986	NULL
.	NULL

Effect	NULL
of	NULL
antioxidants	NULL
on	NULL
primary	NULL
alloantigen-induced	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

137:2646	NULL
.	NULL

Wu	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
N.	NULL
Meydani	NULL
,	NULL
J.	NULL
Sastre	NULL
,	NULL
M.	NULL
Hayek	NULL
,	NULL
and	NULL
M.	NULL
Meydani	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
vitro	NULL
glutathione	NULL
supplementation	NULL
enhances	NULL
interleukin-2	NULL
production	NULL
and	NULL
mitogenic	NULL
response	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
young	NULL
and	NULL
old	NULL
subjects	NULL
.	NULL

J.	NULL
Nutr	NULL
.	NULL

124:655	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

